{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:41:03Z","timestamp":1781613663563,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Junctophilin-3 belongs to a triprotein junctional complex implicated in the regulation of neuronal excitability and involved in the formation of junctional membrane structures between voltage-gated ion channels and endoplasmic (ryanodine) reticular receptors. A monoallelic trinucleotide repeat expansion located within the junctophilin-3 gene (<jats:italic>JPH3<\/jats:italic>) has been implicated in a rare autosomal dominant (AD) late-onset (and progressive) disorder clinically resembling Huntington disease (HD), and known as HD-like 2 (HDL2; MIM# 606438). Although the exact molecular mechanisms underlying HDL2 has not yet been fully elucidated, toxic gain-of-function of the aberrant transcript (containing the trinucleotide repeat) and loss of expression of (full-length) junctophilin-3 have both been implicated in HDL2 pathophysiology. In this study, we identified by whole exome sequencing (WES) a <jats:italic>JPH3<\/jats:italic> homozygous truncating variant [NM_020655.4: c.17405dup; p.(Val581Argfs*137)]. in a female individual affected with genetically undetermined neurodevelopmental anomalies (including delayed motor milestones, abnormal social communication, language difficulties and borderline cognitive impairment) and paroxysmal attacks of dystonia since her early infancy. Our study expands the <jats:italic>JPH3<\/jats:italic>-associated mutational spectrum and clinical phenotypes, implicating the loss of Junctophilin-3 in heterogeneous neurodevelopmental phenotypes and early-onset paroxysmal movement disorders.<\/jats:p>","DOI":"10.1038\/s41431-021-00866-1","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T04:02:35Z","timestamp":1617681755000},"page":"1027-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Allelic and phenotypic heterogeneity in Junctophillin-3 related neurodevelopmental and movement disorders"],"prefix":"10.1038","volume":"29","author":[{"given":"Thomas","family":"Bourinaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkyoni","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-9877","authenticated-orcid":false,"given":"Stephanie","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-7921","authenticated-orcid":false,"given":"Vincenzo","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-7777","authenticated-orcid":false,"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"issue":"Feb","key":"866_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.22598","volume":"71","author":"AI Seixas","year":"2012","unstructured":"Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, et al. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann Neurol. 2012;71(Feb):245\u201357.","journal-title":"Ann Neurol"},{"issue":"Dec","key":"866_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.1124","volume":"50","author":"RL Margolis","year":"2001","unstructured":"Margolis RL, O\u2019Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, et al. A disorder similar to Huntington\u2019s disease is associated with a novel CAG repeat expansion. Ann Neurol. 2001;50(Dec):373\u201380.","journal-title":"Ann Neurol"},{"key":"866_CR3","unstructured":"Anderson DG, Krause A, Margolis RL. Huntington Disease-Like 2 [Internet]. University of Washington, Seattle, Seattle (WA); 1993. http:\/\/europepmc.org\/books\/NBK1529"},{"issue":"Dec","key":"866_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng760","volume":"29","author":"SE Holmes","year":"2001","unstructured":"Holmes SE, O\u2019Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet. 2001;29(Dec):377\u20138.","journal-title":"Nat Genet"},{"issue":"May","key":"866_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1152\/physiolgenomics.00017.2009","volume":"37","author":"A Garbino","year":"2009","unstructured":"Garbino A, van Oort RJ, Dixit SS, Landstrom AP, Ackerman MJ, Wehrens XHT. Molecular evolution of the junctophilin gene family. Physiol Genom. 2009;37(May):175\u201386.","journal-title":"Physiol Genom"},{"issue":"Oct","key":"866_CR6","first-page":"573","volume":"168","author":"A Krause","year":"2015","unstructured":"Krause A, Mitchell C, Essop F, Tager S, Temlett J, Stevanin G, et al. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet Part B, Neuropsychiatr Genet Off Publ Int Soc. Psychiatr Genet. 2015;168(Oct):573\u201385.","journal-title":"Psychiatr Genet"},{"issue":"Oct","key":"866_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/mds.21672","volume":"22","author":"S Bardien","year":"2007","unstructured":"Bardien S, Abrahams F, Soodyall H, van der Merwe L, Greenberg J, Brink T, et al. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov Disord. 2007;22(Oct):2083\u20139.","journal-title":"Mov Disord"},{"issue":"Mar","key":"866_CR8","first-page":"200","volume":"98","author":"DS Magazi","year":"2008","unstructured":"Magazi DS, Krause A, Bonev V, Moagi M, Iqbal Z, Dludla M, et al. Huntington\u2019s disease: genetic heterogeneity in black African patients. S Afr Med J. 2008;98(Mar):200\u20133.","journal-title":"S Afr Med J"},{"issue":"Mar","key":"866_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajhg.2019.01.013","volume":"104","author":"EE Palmer","year":"2019","unstructured":"Palmer EE, Hong S, Al Zahrani F, Hashem MO, Aleisa FA, Ahmed HMJ, et al. Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome. Am J Hum Genet. 2019;104(Mar):542\u201352.","journal-title":"Am J Hum Genet"},{"issue":"Oct","key":"866_CR10","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/brain\/awz248","volume":"142","author":"S Efthymiou","year":"2019","unstructured":"Efthymiou S, Salpietro V, Malintan N, Poncelet M, Kriouile Y, Fortuna S, et al. Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination. Brain 2019;142(Oct):2948\u201364.","journal-title":"Brain"},{"issue":"Apr","key":"866_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ajhg.2019.02.016","volume":"104","author":"V Salpietro","year":"2019","unstructured":"Salpietro V, Malintan NT, Llano-Rivas I, Spaeth CG, Efthymiou S, Striano P, et al. Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment. Am J Hum Genet. 2019;104(Apr):721\u201330.","journal-title":"Am J Hum Genet"},{"issue":"Jul","key":"866_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1006\/bbrc.2000.3011","volume":"273","author":"M Nishi","year":"2000","unstructured":"Nishi M, Mizushima A, Nakagawara KI, Takeshima H. Characterization of human junctophilin subtype genes. Biochem Biophys Res Commun. 2000;273(Jul):920\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Mar","key":"866_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.21081","volume":"61","author":"DD Rudnicki","year":"2007","unstructured":"Rudnicki DD, Holmes SE, Lin MW, Thornton CA, Ross CA, Margolis RL. Huntington\u2019s disease-like 2 is associated with CUG repeat-containing RNA foci. Ann Neurol. 2007;61(Mar):272\u201382.","journal-title":"Ann Neurol"},{"issue":"Jun","key":"866_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2014.02.004","volume":"20","author":"AP Landstrom","year":"2014","unstructured":"Landstrom AP, Beavers DL, Wehrens XH. The junctophilin family of proteins: from bench to bedside. Trends Mol Med. 2014;20(Jun):353\u201362.","journal-title":"Trends Mol Med."},{"issue":"Aug","key":"866_CR15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/ajmg.a.36569","volume":"164A","author":"AH Seeley","year":"2014","unstructured":"Seeley AH, Durham MA, Micale MA, Wesolowski J, Foerster BR, Martin DM. Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1-q24.2 contiguous gene deletion. Am J Med Genet A. 2014;164A(Aug):2062\u20138.","journal-title":"Am J Med Genet A."},{"issue":"Mar","key":"866_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/aur.1536","volume":"9","author":"X Liu","year":"2016","unstructured":"Liu X, Shimada T, Otowa T, Wu Y-Y, Kawamura Y, Tochigi M, et al. Genome-wide Association Study of Autism Spectrum Disorder in the East Asian Populations. Autism Res. 2016;9(Mar):340\u20139.","journal-title":"Autism Res"},{"issue":"Jan","key":"866_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.celrep.2017.12.056","volume":"22","author":"J Coleman","year":"2018","unstructured":"Coleman J, Jouannot O, Ramakrishnan SK, Zanetti MN, Wang J, Salpietro V, et al. PRRT2 Regulates Synaptic Fusion by Directly Modulating SNARE Complex Assembly. Cell Rep. 2018;22(Jan):820\u201331.","journal-title":"Cell Rep."},{"issue":"Apr","key":"866_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ajhg.2016.02.015","volume":"98","author":"NE Mencacci","year":"2016","unstructured":"Mencacci NE, Kamsteeg E-J, Nakashima K, R\u2019Bibo L, Lynch DS, Balint B, et al. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions. Am J Hum Genet. 2016;98(Apr):763\u201371.","journal-title":"Am J Hum Genet"},{"issue":"Mar","key":"866_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/mds.27286","volume":"33","author":"V Salpietro","year":"2018","unstructured":"Salpietro V, Perez-Due\u00f1as B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, et al. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea. Mov Disord. 2018;33(Mar):482\u20138.","journal-title":"Mov Disord"},{"issue":"Dec","key":"866_CR20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.27523","volume":"33","author":"F Niccolini","year":"2018","unstructured":"Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, et al. PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology. Mov Disord. 2018;33(Dec):1961\u20135.","journal-title":"Mov Disord"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00866-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-021-00866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:34Z","timestamp":1684616554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00866-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1038\/s41431-021-00866-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}